Waltering K - Search Results

1

BRCA2 mutations in 154 finnish male breast cancer patients.

Syrjäkoski K, Kuukasjärvi T, Waltering K, Haraldsson K, Auvinen A, Borg A, Kainu T, Kallioniemi OP, Koivisto PA. Syrjäkoski K, et al. Among authors: waltering k. Neoplasia. 2004 Sep-Oct;6(5):541-5. doi: 10.1593/neo.04193. Neoplasia. 2004. PMID: 15548363 Free PMC article.

2

Somatic mutation analysis of MYH11 in breast and prostate cancer.

Alhopuro P, Karhu A, Winqvist R, Waltering K, Visakorpi T, Aaltonen LA. Alhopuro P, et al. Among authors: waltering k. BMC Cancer. 2008 Sep 17;8:263. doi: 10.1186/1471-2407-8-263. BMC Cancer. 2008. PMID: 18796164 Free PMC article.

3

Screening of genetic and expression alterations of SRC1 gene in prostate cancer.

Mäki HE, Waltering KK, Wallén MJ, Martikainen PM, Tammela TL, van Weerden WM, Vessella RL, Visakorpi T. Mäki HE, et al. Among authors: waltering kk. Prostate. 2006 Sep 15;66(13):1391-8. doi: 10.1002/pros.20427. Prostate. 2006. PMID: 16894533

4

Mutation analysis of aryl hydrocarbon receptor interacting protein (AIP) gene in colorectal, breast, and prostate cancers.

Georgitsi M, Karhu A, Winqvist R, Visakorpi T, Waltering K, Vahteristo P, Launonen V, Aaltonen LA. Georgitsi M, et al. Among authors: waltering k. Br J Cancer. 2007 Jan 29;96(2):352-6. doi: 10.1038/sj.bjc.6603573. Br J Cancer. 2007. PMID: 17242703 Free PMC article.

5

Mutation screening of the androgen receptor promoter and untranslated regions in prostate cancer.

Waltering KK, Wallén MJ, Tammela TL, Vessella RL, Visakorpi T. Waltering KK, et al. Prostate. 2006 Nov 1;66(15):1585-91. doi: 10.1002/pros.20387. Prostate. 2006. PMID: 16927275

6

MicroRNA expression profiling in prostate cancer.

Porkka KP, Pfeiffer MJ, Waltering KK, Vessella RL, Tammela TL, Visakorpi T. Porkka KP, et al. Among authors: waltering kk. Cancer Res. 2007 Jul 1;67(13):6130-5. doi: 10.1158/0008-5472.CAN-07-0533. Cancer Res. 2007. PMID: 17616669

7

Androgen receptor (AR) aberrations in castration-resistant prostate cancer.

Waltering KK, Urbanucci A, Visakorpi T. Waltering KK, et al. Mol Cell Endocrinol. 2012 Sep 5;360(1-2):38-43. doi: 10.1016/j.mce.2011.12.019. Epub 2012 Jan 8. Mol Cell Endocrinol. 2012. PMID: 22245783 Review.

8

Chemical castration and anti-androgens induce differential gene expression in prostate cancer.

Lehmusvaara S, Erkkilä T, Urbanucci A, Waltering K, Seppälä J, Larjo A, Tuominen VJ, Isola J, Kujala P, Lähdesmäki H, Kaipia A, Tammela TLj, Visakorpi T. Lehmusvaara S, et al. Among authors: waltering k. J Pathol. 2012 Jul;227(3):336-45. doi: 10.1002/path.4027. Epub 2012 May 8. J Pathol. 2012. PMID: 22431170 Clinical Trial.

9

Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.

Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T. Waltering KK, et al. Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6. Cancer Res. 2009. PMID: 19808968

10

Androgen regulation of micro-RNAs in prostate cancer.

Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T. Waltering KK, et al. Prostate. 2011 May;71(6):604-14. doi: 10.1002/pros.21276. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945501

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters